why choose us

First received: November 14, 2025

Clinical Trial: A Study Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Subjects

Study Type: INTERVENTIONAL


Official Title: A Randomized, Single-Center, Open-Label, Single-Dose, 4-Period, 2-Sequence, Fully Replicate Crossover Study To Assess The Bioequivalence Of A Test Fixed Dose Combination Product Versus The Co-Administ

Brief Summary: Monotherapies for lowering LDL-C often do not achieve target lipid levels because they act on a single pathway, which may be insufficient in patients with high cardiovascular risk or complex lipid profiles.Triple combination therapies, targeting multiple mechanisms of cholesterol metabolism simultaneously, have demonstrated superior LDL-C reduction and better achievement of guideline recommended LDL-C goals.Additionally, combining treatments into a single regimen can improve patient adherence and compliance,…

Read more